Evoq Bio therapy for bacterial lung infections moves closer to testing
FDA meeting on inhaled nanoparticle therapy called ‘a major milestone’ By Marisa Wexler, MS | May 22, 2024 Evoq Bio said it successfully completed a meeting with the U.S. Food and Drug Administration (FDA), held to discuss the development of its inhaled nanoparticle therapy for treating bacterial lung infections in people with cystic fibrosis (CF) […]
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA
By Mark Tullis | May 15th, 2024 EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the preclinical and clinical development plan for an inhaled therapeutic to treat pulmonary bacterial infections. The inhaled therapeutic uses […]
Ingenion Medical Obtains CE Mark for Catheter
Ross Law | April 23, 2024 The cymactive catheter is the first in a pipeline of urology solutions the UK-based company has planned. “US-based nanoscience company EVŌQ Nano’s antimicrobial medical device platform recently demonstrated effectiveness against the world’s leading pathogens implicated in healthcare-associated infections (HAIs).” Ingenion Medical has announced the receipt of a CE mark […]